These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24512718)

  • 21. Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity.
    Satwani P; Bavishi S; Saha A; Zhao F; Ayello J; van de Ven C; Chu Y; Cairo MS
    Cytotherapy; 2014 Oct; 16(10):1431-40. PubMed ID: 24856896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Sevoflurane on Natural Killer Group 2, Member D-Mediated Immune Response in Non-Small-Cell Lung Cancer: An In Vitro Study.
    Jeon S; Kim HK; Kwon JY; Baek SH; Ri HS; Choi HJ; Cho HR; Lee YS; Kim JY; Kim J; Bae J; Lee HJ
    Med Sci Monit; 2020 Nov; 26():e926395. PubMed ID: 33139690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma.
    Liu YF; Chiang Y; Hsu FM; Tsai CL; Cheng JC
    Front Oncol; 2022; 12():1009089. PubMed ID: 36185276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histamine reduces susceptibility to natural killer cells via down-regulation of NKG2D ligands on human monocytic leukaemia THP-1 cells.
    Nagai Y; Tanaka Y; Kuroishi T; Sato R; Endo Y; Sugawara S
    Immunology; 2012 May; 136(1):103-14. PubMed ID: 22304689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxyurea upregulates NKG2D ligand expression in myeloid leukemia cells synergistically with valproic acid and potentially enhances susceptibility of leukemic cells to natural killer cell-mediated cytolysis.
    Lu X; Ohata K; Kondo Y; Espinoza JL; Qi Z; Nakao S
    Cancer Sci; 2010 Mar; 101(3):609-15. PubMed ID: 20028385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer.
    López-Soto A; Folgueras AR; Seto E; Gonzalez S
    Oncogene; 2009 Jun; 28(25):2370-82. PubMed ID: 19430493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The histone deacetylase inhibitor SAHA simultaneously reactivates HIV-1 from latency and up-regulates NKG2D ligands sensitizing for natural killer cell cytotoxicity.
    Desimio MG; Giuliani E; Doria M
    Virology; 2017 Oct; 510():9-21. PubMed ID: 28689087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation.
    Andresen L; Skovbakke SL; Persson G; Hagemann-Jensen M; Hansen KA; Jensen H; Skov S
    J Immunol; 2012 Feb; 188(4):1847-55. PubMed ID: 22227571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70.
    Bae JH; Kim JY; Kim MJ; Chang SH; Park YS; Son CH; Park SJ; Chung JS; Lee EY; Kim SH; Kang CD
    J Immunother; 2010 May; 33(4):391-401. PubMed ID: 20386467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate.
    Chávez-Blanco A; De la Cruz-Hernández E; Domínguez GI; Rodríguez-Cortez O; Alatorre B; Pérez-Cárdenas E; Chacón-Salinas R; Trejo-Becerril C; Taja-Chayeb L; Trujillo JE; Contreras-Paredes A; Dueñas-González A
    Int J Oncol; 2011 Dec; 39(6):1491-9. PubMed ID: 21805029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ataxia-telangiectasia mutated kinase-mediated upregulation of NKG2D ligands on leukemia cells by resveratrol results in enhanced natural killer cell susceptibility.
    Luis Espinoza J; Takami A; Trung LQ; Nakao S
    Cancer Sci; 2013 Jun; 104(6):657-62. PubMed ID: 23445485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway.
    Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F
    Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide.
    Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD
    J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma.
    Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A
    Front Immunol; 2018; 9():1282. PubMed ID: 29963042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of sevoflurane on metalloproteinase and natural killer group 2, member D (NKG2D) ligand expression and natural killer cell-mediated cytotoxicity in breast cancer: an in vitro study.
    Kim HJ; Jeon S; Lee HJ; Bae J; Ri HS; Hong JM; Paek SI; Kwon SK; Kim JR; Park S; Yun EJ
    Korean J Anesthesiol; 2023 Dec; 76(6):627-639. PubMed ID: 37435613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
    Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
    Front Immunol; 2020; 11():40. PubMed ID: 32082316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells.
    Qi YY; Lu C; Ju Y; Wang ZE; Li YT; Shen YJ; Lu ZM
    Asian Pac J Cancer Prev; 2014; 15(18):7857-61. PubMed ID: 25292077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.
    Jimenez-Perez MI; Jave-Suarez LF; Ortiz-Lazareno PC; Bravo-Cuellar A; Gonzalez-Ramella O; Aguilar-Lemarroy A; Hernandez-Flores G; Pereira-Suarez AL; Daneri-Navarro A; del Toro-Arreola S
    BMC Immunol; 2012 Feb; 13():7. PubMed ID: 22316211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer.
    Huang B; Sikorski R; Sampath P; Thorne SH
    J Immunother; 2011 Apr; 34(3):289-96. PubMed ID: 21389869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the HDAC/Suv39/G9a pathway restores the expression of DNA damage-dependent major histocompatibility complex class I-related chain A and B in cancer cells.
    Nakajima NI; Niimi A; Isono M; Oike T; Sato H; Nakano T; Shibata A
    Oncol Rep; 2017 Aug; 38(2):693-702. PubMed ID: 28677817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.